|
2.- DIAGNOSI E TRATTAMENTO
2.1. Valutazione e Procedure Diagnostiche
Napper L., Fisher D., Johnson M., Wood M., The reliability and validity of drug users' self reports of amphetamine use among primarily heroin and cocaine users., Addictive Behaviors, 2010; 35 (4): 350 – 354
Marsden J., Farrell M., Bradbury C., Dale-Perera A., Eastwood B., Roxburgh M., Taylor S., Development of the treatment outcomes profile, Addiction, 2008; 103 (9): 1450 - 1460
Humeniuk R., Ali R., Babor T., Farrell M., Formigoni M., Jittiwutikarn J., et al., Validation of the alcohol, smoking and substance involvement screening test (ASSIST), Addiction, 2008; 103 (6): 1039 – 1047
Merle Gordon S., Aaron J., Greenfield S., Cohen L., Killeen T., Roman P., Assessment and treatment of co-occurring eating disorders in publicly funded addiction treatment programs., Psychiatric Services, 2008; 59 (9): 1056 - 1059
Koob G., A role for brain stress systems in addiction, Neuron, 2008; 59 (1): 11 -34
Amato L., Minozzi S., Davoli M., Vecchi S., Ferri M., Mayet S., Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification, Cochrane Database of Systematic Reviews, 2008; 16 (3)
Merlo L., Gold M., Increased Assessment and Monitoring Needed for Patients Receiving Methadone, The American Journal of Medicine, 2008; 121 (5): 23 - 23
Teesson M., Mills K., Ross J., Darke S., Williamson A., Havard A., The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS), Addiction, 2008; 103 (1): 80 – 88
Gibbons R., Weiss D., Kupfer D., Frank E., Fagiolini A., Grochocinski V., et al., Using computerized adaptive testing to reduce the burden of mental health assessment, Psychiatric Services, 2008; (59): 361-368
Dubois-Arber, F., Benninghoff F., Jeannin A., Typology of injection profiles of clients of a supervised drug consumption facility in geneva, switzerland, European Addiction Research, 2008; 14 (1): 1-10
Jaffee W., Trucco E., Teter C., Levy S., Weiss R., Focus on alcohol & drug abuse: ensuring validity in urine drug testing, Psychiatric services, 2008; (59): 140-142
Nunes K., Firestone P., Baldwin M., Indirect assessment of cognitions of child sexual abusers with the implicit association test, Criminal Justice and Behavior, 2007; 34 (4): 454-475
Consoli A., Scaroina E., Bennardo A., Adattamento del TEEN-ASI nei contesti operativi italiani, Periodico di Informazione e Confronto sulle Patologie da Dipendenza. Dal Fare al Dire, 2007; 3: 31-34
Meyers K., Hagan T., McDermott P., Webb A., Randall M., Frantz J., Factor structure of the Comprehensive Adolescent Severity Inventory (CASI): results of reliability, validity, and generalizability analyses, American Journal of Drug and Alcohol Abuse, 2006; 32 (3): 287-310
Dale A., Patrick L., The marijuana screening inventory (MSI-X): concurrent, convergent and discriminant validity with multiple measures, American Journal of Drug and Alcohol Abuse, 2006; 32 (3): 351-378
2.2. Trattamenti ed Interventi Riabilitativi
SAMHSA News Bulletin., Increasing substance abuse levels among older adults likely to create sharp rise in need for treatment services in next decade, 2010
Hien D., Jiang H., Campbell A., Hu M., Miele G., Cohen L., et al., Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's Clinical Trials Network., The American Journal of Psychiatry, 2010; 167 (1): 95 – 101
Male methamphetamine-user inmates in prison treatment: During-treatment outcomes., Joe G., Rowan-Szal G., Greener J., Simpson D., Vance J., Journal of Substance Abuse Treatment, 2010; 38 (2): 141 – 152
Alvarez Y., Farré M., Fonseca F., Torrens M., Anticonvulsant drugs in cocaine dependence: a systematic review and meta-analysis., Journal of Substance Abuse Treatment, 2010; 38 (1): 67 - 73
Raven M., Carrier E., Lee J., Billings J., Marr M., Gourevitch M., Substance use treatment barriers for patients with frequent hospital admissions., Journal of Substance Abuse Treatment, 2010; 38 (1): 22 -30
Garner B., Godley M., Funk R., Lee M., Garnick D., The Washington Circle continuity of care performance measure: predictive validity with adolescents discharged from residential treatment., Journal of Substance Abuse Treatment, 2010; 38 (1): 3 – 11
Gil-Rivas V., Prause J., Grella C., Substance use after residential treatment among individuals with co-occurring disorders: the role of anxiety/depressive symptoms and trauma exposure., Psychology of Addictive Behaviors, 2009; 23 (2): 303 – 314
Hulse G., Morris N., Arnold-Reed D., et al., Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone., Journal of Substance Abuse Treatment, 2009; 66 (10): 1108 - 1115
McKay J., Continuing care research: what we have learned and where we are going., Journal of Substance Abuse Treatment, 2009; 36: 131 - 145
Brodie J., Case B., Figueroa E., Dewey S., Robinson J., Wanderling J., Randomized, double-blind, placebo-controlled trial of Vigabatrin for the treatment of cocaine dependence in Mexican parolees., The American Journal of Psychiatry, 2009; 166: 1269 – 1277
Dalakas M., Toxic and drug-induced myopathies., Journal of Neurology, Neurosurgery & Psychiatry, 2009; 80 (8): 832 – 838
Berglind W., Whitfield Jr. T., LaLumiere R., Kalivas P., McGinty J., A single intra-PFC infusion of BDNF prevents cocaine-induced alterations in extracellular glutamate within the nucleus accumbens., The Journal of Neuroscience, 2009; 29(12): 3715 - 3719
Pettinatia H., Kampmana K., Lyncha K., Xiea H., Dackisa Ch., Rabinowitza R., et al., A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependance., Addictive Behaviors, 2008; 33(5): 651 - 667
Brady K., Expanding Treatment Options for Cocaine Dependence., The American Journal of Psychiatry, 2009; 166 (11): 1209 - 1210
Latkin C., Identifying neighborhood stressors in assessment of drug treatment continuity and relapse., The American Journal of Psychiatry, 2009; 166 (11): 1207 - 1208
Cranford J., Eisenberg D., Serras A., Substance use behaviors, mental health problems, and use of mental health services in a probability sample of college students., Addictive Behaviors., 2009; 34 (2): 134 - 145
Mitcheson L., Bhavsar K., McCambridge J., Randomized trial of training and supervision in motivational interviewing with adolescent drug treatment practitioners., Journal of Substance Abuse Treatment., 2009; 37 (1): 73 – 78
Brady K., Expanding treatment options for cocaine dependence., The American Journal of Psychiatry, 2009; 166 (11): 1209 - 1210
The Substance Abuse and Mental Health Services Administration (SAMHSA)., New Manual Provides Guidance on Addressing Suicidal Thoughts and Behaviors in Substance Abuse Treatment., 2009
Chung T, Maisto S., "What I got from treatment": predictors of treatment content received and association of treatment content with 6-month outcomes in adolescents., Journal of Substance Abuse Treatment, 2009; 37 (2): 171- 181
Greaves A., Best D., Day E., Foster A., Young people in coerced drug treatment: Does the UK Drug Intervention Programme provide a useful and effective service to young offenders?, Addiction Research and Theory, 2009; 17 (1): 17 – 29
Wong E., Longshore D., Ethnic Identity, Spirituality, and Self-Efficacy Influences on Treatment Outcomes Among Hispanic American Methadone Maintenance Clients, Journal of Ethnicity in Substance Abuse, 2008; 7 (3): 328 – 340
Stallwitz A., Stöver H., The impact of substitution treatment in prisons--a literature review, The International Journal on Drug Policy, 2007; 18 (6): 464 – 474
Gyarmathy A., Latkin C., Individual and social factors associated with participation in treatment programs for drug users, Substance Use & Misuse, 2008; 43 (12 -13): 1865 – 1881
Novak S., Herman-Stahl M., Flannery B., Zimmerman M., Physical pain, common psychiatric and substance use disorders, and the non-medical use of prescription analgesics in the United States, Drug and Alcohol Dependence, 2008
Bobrova N., Rughnikov U., Neifeld E., Rhodes T., Alcorn R., Kirichenko S., et al., Challenges in providing drug user treatment services in Russia: providers' views, Substance Use & Misuse, 2008; 43 (12 -13): 1770 – 1784
Holt M., Treloar C., Understanding comorbidity? Australian service-user and provider perspectives on drug treatment and mental-health literacy, Drugs - Education Prevention and Policy, 2008; 15 (6): 518 - 531
Roux P., Villes V., Blanche J., Bry D., Spire B., Feroni I., et al., Buprenorphine in primary care: risk factors for treatment injection and implications for clinical management, Drug and Alcohol Dependence, 2008; 97 (1-2): 105 – 113
Ghitza U., Epstein D., Preston K., Self-report of illicit benzodiazepine use on the Addiction Severity Index predicts treatment outcome , Drug and Alcohol Dependence, 2008; 97(1-2):150-7
Lawrinson P., Ali R., Buavirat A., Chiamwongpaet S., Dvoryak S., Habrat B., et al., Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS, Addiction, 2008; 103 (9): 1484 – 1492
McKetin R., Ross J., Kelly E., Baker A., Lee N., Lubman D., et al., Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants, Drug and Alcohol Review, 2008; 27 (3): 277 - 285
Elovich R., Drucker E., On drug treatment and social control: Russian narcology's great leap backwards, Harm Reduction Journal, 2008; 5: 23
Hoda Z., Kerr T., Li K., Montaner J., Wood E., Prevalence and correlates of jugular injections among injection drug users, Drug and Alcohol Review, 2008; 27(4): 442 - 446
Ross M., McCurdy S., Kilonzo G., Williams M., Leshabari M., Drug use careers and blood-borne pathogen risk behavior in male and female Tanzanian heroin injectors, The American Journal of Tropical Medicine and Hygiene, 2008; 79 (3): 338 – 343
Henskens R., Garretsen H., Bongers I., Van Dijk A., Sturmans F., Effectiveness of an outreach treatment program for inner city crack abusers: compliance, outcome, and client satisfaction, Substance Use & Misuse, 2008; 43 (10): 1464 – 1475
Fernndez-Montalvo J., Lopez-Goi J., Illescas C., Landa N., Lorea I., Evaluation of a therapeutic community treatment program: a long-term follow-up study in Spain, Substance Use & Misuse, 2008; 43 (10): 1362 – 1377
Buckland P., Will we ever find the genes for addiction?, Addiction, 2008; 103 (11): 1768 - 1776
Strang J., Manning V., Mayet S., Best D., Titherington E., Santana L., et al., Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses, Addiction, 2008; 103 (9): 1648 - 1657
Morgan P., Pace-Schott E., Sahul Z., Coric V., Stickgold R., Malison R., Sleep architecture, cocaine and visual learning, Addiction, 2008; 103 (8): 1344 – 1352
Dobscha S., Corson K., Flores J., Tansill E., Gerrity M., Veterans affairs primary care clinicians' attitudes toward chronic pain and correlates of opioid prescribing rates, Pain Medicine, 2008; 9 (5): 564 – 571
Green T., Heimer R., Grau L., Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States, Addiction, 2008; 103 (6): 979 - 989
Marina D., Improving research to evaluate the effects of psychological treatments for addiction, Addiction, 2008; 103 (6): 888 – 889
Laffaye C., McKellar J., Ilgen M., Moos R., Predictors of 4-year outcome of community residential treatment for patients with substance use disorders, Addiction, 2008; 103 (4): 671 - 680
Kerr D., Dietze P., Kelly A., Intranasal naloxone for the treatment of suspected heroin overdose, Addiction, 2008; 103 (3): 379 – 386
Hoda Z., Kerr T., Li K., Montaner J., Wood E., Prevalence and correlates of jugular injections among injection drug users, Drug and Alcohol Review, 2008; 27(4): 442-6
McMahon T., Winkel J., Rounsaville B., Drug abuse and responsible fathering: a comparative study of men enrolled in methadone maintenance treatment, Addiction, 2008; 103 (2): 269 - 283
Finney J., Regression to the mean in substance use disorder treatment research, Addiction, 2008; 103 (1): 42 – 52
Biederman J., Monuteaux M., Spencer T., Wilens T., MacPherson H., Faraone S., Stimulant Therapy and Risk for Subsequent Substance Use Disorders in Male Adults With ADHD: A Naturalistic Controlled 10-Year Follow-Up Study, The American Journal of Psychiatry, 2008; 165 (5): 597 – 603
Gorelick D., Addiction Treatment: Science and Policy for the Twenty-First Century, The American Journal of Psychiatry, 2008; 165 (7): 923 – 924
Volkow N., Swanson J., Does Childhood Treatment of ADHD With Stimulant Medication Affect Substance Abuse in Adulthood?, The American Journal of Psychiatry, 2008; 165 (5): 533 - 555
Mannuzza S., Klein R., Truong N., Moulton J., Roizen E., Howell K., Castellanos F., Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood, The American Journal of Psychiatry, 2008; 165 (5): 604 – 609
Anderson D., The state of the art in the treatment, today and tomorrow, A Journal of the National Institute on Drug Abuse,. 2008; 4 (2): 3
Woodward A., Raskin I., Blacklow B., A profile of the susbstance abuse treatment industry: organization, costs, and treatment completion, Substance Use & Misuse, 2008; 43 (5): 647– 679
Phillips R., Bourne H., The impact of worker values on client outcomes within a drug treatment service, The international Journal of Drug Policy, 2008; 19 (1): 33 - 41
Kampman K., The search for medications to treat stimulant dependence, A Journal of the National Institute on Drug Abuse,. 2008; 4 (2): 28 - 35
Savage S., Kirsh K., Passik S., Challenges in using opioids to treat pain in person with substance use disorders, A Journal of the National Institute on Drug Abuse,. 2008; 4 (2): 4 – 27
Melnick G., Wexler H., Cleland C., Client consensus on beliefs about abstinence: effects on substance abuse treatment outcomes, Drug and Alcohol Dependence, 2008; 93 (1-2): 30 – 37
Christie M., Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction, British Journal of Pharmacology, 2008; 154 (2): 384–396
Miller G., Psychopharmacology. Tackling alcoholism with drugs, Science, 2008; 320 (5873): 168 – 170
Ngo H., Tait R., Hulse G., Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation, Archives of General Psychiatry, 2008; 65(4): 466-475
Orford J., Asking the right questions in the right way: the need for a shift in research on psychological treatments for addiction, Addiction, 2008; 103 (6): 875 - 885
Quaglio G., Lugoboni F., Pattaro C., Melara B., Mezzelani P., Des Jarlais C., Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment, Drug and Alcohol Dependence, 2008; 94 (1-3): 12 – 18
Prosser J., Steinfeld M., Cohen L., Derbyshire S., Eisenberg D., Cruciani R., et al., Abnormal heat and pain perception in remitted heroin dependence months after detoxification from methadone-maintenance, Drug and Alcohol Dependence, 2008; 95 (3): 237 – 244
Wittchen H., Apelt S., Soyka M., Gastpar M., Backmund M., Gölz J., et al., Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients, Drug and Alcohol Dependence, 2008; 95 (3): 245 – 257
Best D., Day E., Homayoun S., Lenton H., Moverley R., Openshaw M., Treatment retention in the Drug Intervention Programme: Do primary drug users fare better than primary offenders?, Drugs Education Prevention and Policy, 2008; 15 (2): 201-209
Strang J., Manning V., Mayet S., Titherington E., Offor L., Semmler C., et al., Family carers and the prevention of heroin overdose deaths: Unmet training need and overlooked intervention opportunity of resuscitation training and supply of naloxone, Drugs Education Prevention and Policy, 2008; 15 (2): 211-218
Fischer J., Neale J., Involving drug users in treatment decisions: An exploration of potential problems, Drugs Education Prevention and Policy, 2008; 15 (2): 161-175
Crome I., Bloor R., Frisher M., Self-harm and substance misuse in the UK - key issues for treatment and research, Drugs Education Prevention and Policy, 2008; 15 (2): 121-127
Hill K., Helping the addict you love: the new effective program for getting the addict into treatment, Psychiatric Services, 2008; (59): 218
Kedia S., Relyea G., Gender effects on client-spousal collateral agreement levels in substance abuse posttreatment reports, Addiction Research and Theory, 2008; 16 (1): 23-36
Khantzian E., The science of addiction: from neurobiology to treatment, Psychiatric Services, 2008; (59): 217
Seward G., Patients with substance abuse problems: effective identification, diagnosis, and treatment, Psychiatric Services, 2008, (59): 217-218
McMahon T., Winkel J., Rounsaville B., Drug abuse and responsible fathering: a comparative study of men enrolled in methadone maintenance treatment, Addiction, 2008; 103 (2): 269-283
McCarty D., Fuller B., Arfken C., Miller M., Nunes E., Edmundson E., et al., Direct care workers in the national drug abuse treatment clinical trials network: characteristics, opinions, and beliefs, Psychiatric Services, 2007; (58): 181-190
Ford J., Smith S., Complex posttraumatic stress disorder in trauma-exposed adults receiving public sector outpatient substance abuse disorder treatment, Addiction Research and Theory, 2008; 16 (2): 193 - 203
Bergmark A., On treatment mechanisms-what can we learn from the combine study?, Addiction, 2008; 103 (5): 703 - 705
Kolind T., Form or content: the application of user perspective in treatment research, Drugs- Education Prevention and Policy, 2007; 14 (3): 261-275
Staiger P., Kambouropoulos N., Dawe S., Should personality traits be considered when refining substance misuse treatment programs?, Drug and Alcohol Review, 2007; 26 (1): 17-23
Yucel M., Lubman D., Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention, Drug and Alcohol Review, 2007; 26 (1): 33-39
Ball A., HIV, injecting drug use and harm reduction: a public health response, Addiction, 2007; 102 (5): 684-690
Whitten L., Serotonin system may have potential as a target for cocaine medications, NIDA, 2007; 21 (3): 12-13
Poling J., Kosten T., Sofuoglu M., Treatment outcome predictors for cocaine dependence, American Journal of Drug and Alcohol Abuse, 2007; 33 (2): 191-206
Whitten L., Cocaine abusers’ pretreatment cue responses predict recovery success, NIDA Notes, 2007; 21 (2): 7-8
Shin S., Lundgren L., Chassler D., Examining drug treatment entry patterns among young, The American Journal of Drug and Alcohol Abuse, 2007; 33 (2): 217-226
Gardner T., Kosten T., Human laboratory and neuroimaging studies in substance use disorders:developing new treatment approaches, American Journal of Drug and Alcohol Abuse, 2007; 33 (6): 765-7
Stimson G., “Harm reduction-coming of age”: a local movement with global impact, The International Journal of Drug Policy, 2007; 18 (2): 67-69
Gottfredson D., Kearley B., Najaka S., Rocha C., How drug treatment courts work: an analysis of mediators, Journal of Research in Crime and Delinquency, 2007; 44 (1): 3-35
Bignamini E., De Bernardis A., Delle droghe e delle pene. I tossicodipendenti tra cura e castigo, Publiedit, 2007
Castells X., Casa M., Vidal X., Bosch R., Roncero C., Ramos-Quiroga J., et al., Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and metaanalysis of randomized controlled clinical trials, Addiction, 2007; 102 (12): 1871-1887
Witkiewitz K., Marlatt A., Therapist’s guide to evidence-based relapse prevention, Academic Press, 2007
Whitten L., Gene experiment confirms a suspected cocaine action, NIDA Notes, 2007; 21 (4): 8-10
Kalechstein A., Wilfred G., Neuropsychology and substance misuse: state of the art and future directions, New York: Psychology Press, 2007
Kornor H., Waal H., Sandvik L., Time-limited buprenorphine replacement therapy for opioid dependence: 2 year follow-up outcomes in relation to programme completion and current agonist therapy status, Drug and Alcohol Review, 2007; 26 (2): 135-141
Gossop M., Stewart D., Marsden J., Readiness for change and drug use outcomes after treatment, Addiction, 2007; 102 (2): 301-308
Poling J., Kosten T., Sofuoglu M., Treatment out come predictors for cocaine dependence, The American Journal of Drug and Alcohol Abuse, 2007; 33 (2): 191-206
Gillespie N., Neale M., Prescott C., Aggen S., Kendler K., Factor and item-response analysis DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids, Addiction, 2007; 102 (6): 920-930
Best D., Day E., Campbell A., Developing a method for conducting needs assessments for drug treatment: a systems approach, Addiction Research and Theory, 2007; 15 (3): 263-275
Chinet L., Plancherel B., Bolognini M., Holzer L., Halfon O., Adolescent substance-use assessment: methodological issues in the use of the adolescent drug abuse diagnosis (ADAD), Substance Use & Misuse, 2007; 42 (10): 1505-1525
Bell E., Time, space and body in adolescent residential services: re-imagining service research, Addiction Research and Theory, 2007; 15 (1): 97-111
Isralowitz R., Reznik A., Gender differences among Israeli adolescents in residential drug treatment, Drugs- Education Prevention and Policy, 2007; 14 (2): 167-172
Caldwell M., McCornick D., Umstead D., Van Rybroek G., treatment progress and therapeutic outcomes among adolescent with psychopathic features, Criminal Justice and Behavior, 2007; 34 (5): 573-567
Kunic D., The computerized assessment of substance abuse (CASA), Forum on Corrections Research, 2006; 18 (1): 19-23
Carpenter K., Aharonovich E., Smith J., Iguchi M., Behavior therapy for depression in drug dependence (BTDD): results of a stage in therapy development pilot, The American Journal of Drug and Alcohol Abuse, 2006; 32 (4): 541-548
Zajdow G., The narrative of evaluation: medically supervised injecting centers, Contemporary Drug Problems. An Interdisciplinary Quarterly, 2006; 33 (3): 399-426
Pamela N., The impact of therapeutic case management on participation in adolescent substance abuse treatment, American Journal of Drug and Alcohol Abuse, 2006; 32 (3): 311-327
Harrow B., Tompkins C., Mitchell P., Smith K., Soldz S., Kasten L., The impact publicly funded managed care on adolescent substance abuse treatment outcomes, American Journal of Drug and Alcohol Abuse, 2006; 32 (3): 379-398
Metrebian N., Carnwath Z., Mott J., Carnwath T., Stimson G., Sell L., Patients receiving a prescription for diamorphine (heroin) in the United Kingdom, Drug and Alcohol Review, vol. 2006; 25 (2): 115-121
Kornor H., Waal H., Ali R., Abstinence oriented buprenorphine replacement therapy for young adults in outpatient counselling, Drug and Alcohol Review, 2006; 25 (2): 123-130
Caplehom J., Deeks J., A critical appraisal of the Australian comparative trial methadone and buprenorphine maintenance, Drug and Alcohol Review, 2006; 25 (2): 157-160
Bell J., Mutch C., Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file review, Drug and Alcohol Review, 2006; 25 (2): 167- 171
Jaffe J., Do antagonist have a role in the treatment of opioid dependence?, Addiction, 2006; 101 (4): 468-469
Johansson B., Berglund M., Lindgren A., Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review, Addiction, 2006; 101 (4): 491-503
Gossop M., Stewart D., Marsden J., Effectiveness of drug and alcohol counselling during methadone treatment: content, frequency, and duration of counselling and association with substance use outcomes, Addiction, 2006; 101 (3): 404-412
Finney J., Moos R., Editorial: Matching client’s treatment goals with treatment oriented towards abstinence or harm reduction, Addiction, 2006; 101 (11): 1540-1543
Coffin P., Blaney S., Fuller C., Vadnai L., Miller S., Vlahov D., Support for buprenorphine and methadone prescription to heroin-dependent patients among New York city physicians, American Journal of Drug and Alcohol Abuse, 2006; 32 (1): 1-6
Fisk D., Rakfeldt J., McCormack E., Assertive outreach: an effective strategy for engaging homeless person with substance use disorders into treatment, American Journal of Drug and Alcohol Abuse, 2006; 32 (3): 479-486
Astone-twerell, J., Strauss S., Hagan H., Des Jarlais., Drug treatment programs HCV service delivery to their HCV positive clients, Addiction Research and Theory, 2006; 14 (3): 289-302
Ulivi G., Linee guida per il trattamento della eroinopatia, Personalità / Dipendenza, 2005; 11 (2): 203-243
Crome LL., Overview: Beyond guidelines and guidance? Psychosocial perspectives on treatment interventions for young people with substance problems in the United Kingdom, Drugs Education Prevention and Policy, 2006; 13 (3): 203-224
Stevens A., Berto D., Frick U., Hunt N., Kerschl V., McSweeney T., et al. The relationship between legal status, perceived pressure and motivation in treatment for drug dependence: results from a
European Study of quasi-compulsory treatment, European Addiction Research, 2006, 12 (4): 197-209
Cosden M., Basch J., Campos E., Greenwell A., Barazani S., Walker S., Effects of motivation and problem severity on court-based drug treatment, Crime and Delinquency, 2006; 52 (4): 599-618
Futterman R., Sapadin K., Silverman S., Transferring psychological technology into substance abuse treatment: substance abuse as a psychiatric illness Addiction Research and Theory, 2006; 14 (3): 265-274
Rampazzo L., De Angeli M., Serpelloni G., Simpson D., Flynn P., Italian Survey of Organizational Functioning and Readiness for Change: a cross-cultural transfer of treatment assessment strategies, European Addiction Research, 2006; 12 (4): 176-181
Breslin K., Malone S., Maintaining the viability and safety of the methadone maintenance treatment program, Journal of Psychoactive Drugs, 2006; 38 (2): 157-160
Brown M., Galloway G., A treatment model for craving identification and management, Journal of Psychoactive Drugs, 2006; 38 (2): 189-202
Schumann G., Hypothalamic-pituitary-adrenal axis and substance use: so many questions and we can answer them, Addiction, 2006; 101 (11): 1538-1539
Huizink A., Ferdinand R., Ormel J., Verhulst F., Hypothalamicpituitary adrenal axis activity and early onset of cannabis use, Addiction, 2006; 101 (11): 1581-1588
Nunes E., Rothenberg J., Sullivan M., Carpenter K., Kleber H., Behavioural therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness? American Journal of Alcohol Abuse, 2006; 32 (4): 503-518
Robertson R., Raab G., Bruce M., McKenzie J., Storkey H., Salter A., Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: a randomized controlled trial, Addiction, 2006; 101 (12): 1752-1759
Barnett P., Masson C., Sorensen J., Wong W., Hall S., Linking opioid-dependent hospital patients to drug treatment: health care and cost 6 months after randomization, Addiction, 2006; 101 (12): 1787-1796
Maremmani I., Forty years of methadone maintenance treatment around the world: past, present and future, Heroin Addiction and Related Clinical Problems, 2006; 8 (3): 7-12
Flego, A., Methadone and treatment quality, the EFQM Excellence, Model Heroin Addiction and Related Clinical Problems, 2006; 8 (3): 13-36
Meier P., Best D., Programme factors that influence completion of residential treatment, Drug and Alcohol Review, 2006; 25 (4): 349-355
Tate S., Brown S., Glasner S., Unrod M., McQuaid J., Chronic life stress, acute stress events, and substance availability in relapse, Addiction Research and Theory, 2006; 14 (3): 303-322
De Wilde J., Broekaert E., Rosseel, Y., Problem severity profiles of clients in european therapeutic communities: gender differences in various areas of functioning, European Addiction Research, 12, 3, 2006, pp. 128-137
Soyes V., De Leon G., Broekaert E., Rosseel Y., The impact of a social network intervention on retention in Belian therapeutic communities: a quasi-experimental study, Addiction 101, 7, 2006, pp. 1027-1034
Fischer G., Ortner R., Rohrmeister K., Jagsch R., Baewert A., Langer M., et al. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study, Addiction, 101, 2, 2006, pp. 275-281
Wayne Hall (Ed.), Stereotactic neurosurgical treatment of addiction: minimizing the chances of another ‘great and desperate cure’, Addiction, 101, 1, 2006, pp. 1-3
Williams N., Nasir R., Smither G., Troon S., Providing opioid substitution treatment to indigenous heroin users within a community health service setting in Adelaide, Drug and Alcohol Review, 25, 3, 2006, pp. 227-232
Cook J., Watser R., Kane W., Ruzek J., Woody G., Dissemination and feasibility of a cognitive - behavioural treatment for substance use disorders and posttraumatic stress disorder in the veterans administration, Journal of Psychoactive Drugs, 38, 1, 2006, pp. 89-92
Crome Llana B., Overview: beyond guidelines and guidance psychosocial perspectives on treatment interventions for young people with substance problems in the United Kingdom, Drugs Education Prevention and Policy, 13, 3, 2006, pp.203-224
Schifano P., Bargagli A.M., Belleudi, V., et al. Methadone treatment in clinical practice in Italy: need for improvement,European Addiction Research, 12, 3, 2006, pp. 121-127
McCabe S.E., Teter Christian J., Boyd Carol J., Medical use, illicit use and diversion of prescription stimulant medication, Journal of Psychoactive drugs, 38, 1, 2006, pp. 43-56
Nord C., Stohler R., Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis, The Lancet, 367, 2006, pp. 1830-1834
Eliason M.J. Are Therapeutic Communities Therapeutic for Women? Substance Abuse Treatment, Prevention and Policy, 1, 3, 2006, pp. 1-7
Broekaert E., Vandevelde S., Soyez V., Yates R., Slater A., The third generation of therapeutic communities: the early development of the TC for addictions in Europe, European Addiction Research, 12, 1, 2006, pp. 1-11
Hiller M., Knight K., Saum Ch., Simpson D., Social functioning, treatment dropout, and recidivism of probationers mandated to a modified therapeutic community, Criminal Justice and Behaviour, 2006; 33 (6): 738-759
Davis K., Devitt T., Rollins A., O’Neill S., Pavick D., Harding B., Integrated residential treatment for persons with severe and persistent mental illness: lessons in recovery, Journal of Psychoactive Drugs, 2006; 38 (3): 263-272
Sigmon C., Mood E., Nuwayser S., Bigelow E., An injection depot formulation of buprenorphine: extended biodelivery and effects, Addiction, 101, 3, 2006, pp. 420-432
Draper J.C., McCance-Katz E.F., Medical illness and comorbidities in drug users: implications for addiction pharmacotherapy treatment, Substance Use & Misuse, 40, 13-14, 2005, pp. 1899-1822
Ziegler P.P., Addiction and the treatment of pain, Substance Use & Misuse, 40, 13-14, 2005, pp. 1945-1954
Cropsey K.L., Villalobos G.C., St. Clair C.L., Pharmacotherapy treatment in substance dependent correctional populations: a Review, Substance Use & Misuse, 40, 13-14, 2005, pp. 1983-2000
Brady K.T., Verduin M.L., Pharmacoterapy of comorbid mood, anxiety and substance use disorders, Substance Use & Misuse, 40, 13-14, 2005, pp. 2021-2042
Campbell T.C., Daood C., Catlin L., Abelson A., Integration of research and practice in substance use disorder treatment: findings from focus groups of clinicians, researchers, educators, administrators and policy makers, Journal of Addictions & Offender Counseling, 26, 1, 2005, pp. 4-14
Sannibale C., Fucito L., O’connor D., Curry K., Process evaluation of an out-patient detoxification service, Drug and Alcohol Review, 24, 6, 2005, pp. 475-481
Ross J., Teesson M., Darke S., Lynskey M., Ali R., Ritter A., et al., The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS), Drug and Alcohol Review, 24, 5, 2005, pp. 411-418
Darke S., Williamson A., Ross J., Teesson M., Non-fatal heroin overdose, treatment exposure and client characteristics: findings from the Australian treatment outcome study (ATOS), Drug and Alcohol Review, 24, 5, 2005, pp. 425-432
Baca T., Grant J., Take-home naloxone to reduce heroin death, Addiction, 100, 12, 2005, pp. 1823-1831
Paterson S., Lintzeris N., Mitchell T.B., Cordero R., Nestor L., Strang J., Validation of techniques to detect illicit heroin use in patients prescribed pharmaceutical heroin for the management of opioid dependence, Addiction, 100, 12, 2005, pp. 1832-1839
Raistrick D., West D., Finnegan O., Thistlethwaite G., Brearley R., Banbery J., A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial, Addiction, 100, 12, 2005, pp. 1860-1867
Carpentier J., De Jong A.J., Dijkstra A.G.,, Verbrugge A.G., Krabbe Paul F.M., A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders, Addiction, 100, 12, 2005, pp. 1868-1874
Klag S., O’Callaghan F., Creed P., The use of legal coercion in the treatment of substance abusers: an overview and critical analysis of thirty years of research, Substance Use & Misuse, 40, 12, 2005, pp. 1777-1798
Strauss S.M., Astone J.M., Munoz-Plaza C., Hagan H., Des Jarlais D., Residential substance user treatment programs as venues for HCV pharmacological treatment: client and staff perspectives, Substance Use & Misuse, 40, 12, 2005, pp.1811-1830
Chen G., Social Support, spiritual program, and addiction recovery, International Journal of Offender Therapy and Comparative Criminology, 50, 3, 2006, pp. 306-323
Brugal M.T., Domingo-Salvany A., Puig R., Barrio G., García de Olalla P., de la Fuente L., Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain, Addiction, 100, 7, 2005, pp. 981
Short D., Frischer M., Supporting the evidence- based treatment of individual drug users: The case for “patient profile decision analysis”, Acta Criminologica, 16, 3, 2005, pp. 143- 147
Vandevelde S., Broekaert E., Schuyten G., Van Hove G., Intellectual abilities and motivation toward substance abuse treatment in drug- involved offenders: a pilot study in the Belgian Criminal Justice System, International Journal of Offender Therapy and Comparative Criminology, 49, 3, 2005, pp. 277
Maxwell J.C., Spence R.T., Profiles of Club drug users in treatment, Substance Use & Misuse, 40, 9-10, 2005, pp. 1409
Levy J.A., Anderson T., The drug career of the older injector, Addiction Research and Theory, 13, 3, 2005, pp. 245
Katz E., King S., Schwartz R., Weintraub E., Barksdale W., Robinson R., Brown B., Cognitive ability as a factor in engagement in drug abuse treatment, American Journal of Drug and Alcohol Abuse, 31, 3, 2005, pp. 359
Ugolini P., Qualità è outcome nelle dipendenze.Dibattito europeo e italiano, esperienze in Emilia Romagna, Franco Angeli 2005
Lucchini A., L’uso della buprenorfina nel trattamento della tossicodipendenza. Due anni di esperienze nei Ser.T, Franco Angeli, 2003
Carpenter G., Drug counselling for cocaine addiction: the collaborative cocaine treatment study model, National Institute on Drug Abuse (NIDA), 2002
2.3. Aspetti Clinici e Terapeutici
Epstein D., Marrone G., Heishman S., Schmittner J., Preston K., Tobacco, cocaine, and heroin: Craving and use during daily life., Addictive Behaviors, 2010; 35 (4): 318 - 324
Epstein D., Willner-Reid J., Vahabzadeh M., Mezghanni M., Lin J., Preston K., Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use., Archives of General Psychiatry, 2009; 66 (1): 88 – 94
Morgan C., Muetzelfeldt L., Curran V., Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls., Addiction, 2009; 104 (1): 77 – 87
Adinoff B., Understanding addiction as self medication: finding hope behind the pain., The American Journal of Psychiatry, 2009; 166 (11): 1301-1302
Kanayama G., Brower K., Wood R., Hudson J., PopeJr H., Anabolic-androgenic steroid dependence: an emerging disorder., Addiction, 2009; 104 (12): 1966 - 1978
Kovac V., Rise J., The role of explicit cognition in addiction: Development of the mental representations scale, Drugs - Education Prevention and Policy, 2008; 16 (6): 595 – 606
Stein D., Classifying hypersexual disorders: compulsive, impulsive, and addictive models, The Psychiatric Clinics of North America, 2008; 31 (4): 587 – 591
Ybrandt H., Brjesson J., Armelius B., The adolescent drug abuse diagnosis composite scores in Swedish normal and antisocial adolescents, Substance Use & Misuse, 2008; 43 (10): 1411 – 1423
Domeyer P., Mostratos Z., Sergentanis T., Mariolis A., Drug addicts and their mother: lack of conflict, Substance Use & Misuse, 2008; 43 (10): 1487 – 1488
Derringer J., Krueger R., McGue M., Iacono W., Genetic and environmental contributions to the diversity of substances used in adolescent twins: a longitudinal study of age and sex effects, Addiction, 2008; 103 (9): 1744 – 1751
Beck A., The evolution of the cognitive model of depression and its neurobiological correlates, The American Journal of Psychiatry, 2008; 165 (8): 969 - 977
Ball D., Addiction science and its genetics, Addiction, 2008; 103 (3): 360 - 367
O’Connor G., McMahon G., Complications of heroin abuse, European Journal of Emergency Medicine, 2008; 15 (2): 104 -106
Newcombe R., Ketamine case study: the phenomenology of a ketamine experience, Addiction Research and Theory, 2008; 16 (3): 209 – 215
Gerra G., Bertacca S., Zaimovic A., Pirani M., Branchi B., Ferri M., Relationships of personality traits and drug of choice by cocaine addicts and heroin addicts, Substance Use & Misuse, 2008; 43 (3 - 4): 317 – 330
Nutt D., Lingford-Hughes A., Addiction: the clinical interface, British Journal of Pharmacology, 2008; 154: 397–405
McNaughton C., Transitions through homelessness, substance use, and the effect of material marginalization and psychological trauma, Drugs Education Prevention and Policy, 2008; 15 (2): 177-188
Lankenau S., Sanders B., Bloom J., Hathazi D., Towards an explanation of subjective ketamine experiences among young injection drug users, Addiction Research and Theory, 2008; 16 (3): 273 – 287
Karow A., Verthein U., Krausz M., Schäfer I., Association of personality disorders, family conflicts and treatment with quality of life in opiate addiction, European Addiction Research, 2008; 14 (1): 38-46
Luoma J., Kohlenberg B., Hayes S., Bunting K., Rye A., Reducing self-stigma in substance abuse through acceptance and commitment therapy: Model, manual development, and pilot outcomes, Addiction Research and Theory, 2008; 16 (2): 149 – 165
Slaski S., Zylicz O., The effect of psychotherapy on self-awareness in incarcerated and non incarcerated alcoholics: a pilot study, International Journal of Offender Therapy and Comparative Criminology, 2006; 50 (5): 559-569
Carpenter K., Aharonovich E., Smith J., Iguchi M., Nunes E., Behaviour therapy for depression in drug dependence (BTDD): results of a stage therapy development pilot, American Journal Drug and Alcohol Abuse, 2006; 32 (4): 541-548
Ridenour T., Maldonado-Molina M., Compton W., Spitznagel E., Cottler L., Factors associated with the transition from abuse to dependence among substance abusers: Implications for a measure of addictive liability, Drug Alcohol Depend, 2005; 80(1): 1–14
Scopetani R., Tossicodipendenza e gruppi, Personalità \ Dipendenze, 2005; 11 (2): 179-188
Humphrey A., The group therapy of substance abuse, David W. Brook and Henry I.Spitz, (Ed.), International Criminal Justice Review, 2005; 15 (2): 185-186
Graziano E., Bernardini S., Zazo M., La tossicodipendenza femminile e i disturbi dell’alimentazione (DA), S&P Salute e Prevenzione Rassegna italiana delle tossicodipendenze, Fascicolo 40, 2005, pp. 83
Taranto A., Cantatore V., Brizzi G., Vita di mare, disfunzione coniugale e psicopatologia della dipendenza, S&P Salute e Prevenzione Rassegna italiana delle tossicodipendenze, Fascicolo 40, 2005, pp. 67
D.B. Leiderman, S. Shoptaw, A. Montgomery, D.A. Bloch, A. Elkashef, J. LoCastro, F. Vocci, RESEARCH REPORT. Cocaine Rapid Efficacy Screening Trial (CREST): a paradigm for the controlled evaluation candidate medications for cocaine dependence, Addiction, 2005, vol.100 - 1 Suppl.
S. Shoptaw, D.W. Watson, C. Reiber, R.A. Rawson, M.A. Montgomery, M.D. Majewska, W. Ling, RESEARCH REPORT. Randomized controlled pilot trial of cabergoline, hydergine and levodopa/carbidopa: Angeles Cocaine Rapid Efficacy Screening Trial (CREST), Addiction, 2005, vol.100 - 1 Suppl.
D.B. Leiderman, S. Shoptaw, A. Montgomery, D.A. Bloch, A. Elkashef, T.H. Holmes, K. Kampman, M.S. Reid, D. Ciraulo, Rotrosen, John - Vocci, Frank, RESEARCH REPORT. Retrospective analyses of pooled data from CREST I and CREST II trials for treatment cocaine dependence, Addiction, 2005, vol.100 - 1 Suppl.
K. Kampman, D.B. Leiderman, T.H. Holmes, J. LoCastro, S. Shoptaw, M.A. Montgomery, D.A. Bloch, A. Elkashef, M.S. Reid, D. Ciraulo, T.M. Winhusen, F. Vocci, RESEARCH REPORT. Cocaine Rapid Efficacy Screening Trials (CREST): lessons learned, Addiction, 2005, vol.100 - 1 Suppl.
C.J. de Wet, L.J. Reed, J. Bearn, The rise of buprenorphine prescribing in England: analysis of NHS regional data, 2001-2003, Addiction, 2005, 100, 4.
B. Trolidal, An investigation of the effect of privatization of retail sales of alcohol on consumption and traffic accidents in Alberta, Canada, Addiction, 2005, 100, 5.
J. Davey, A. Davies, N. French, C. Williams, C. P., Lang Drug driving from a user’s perspective, Drugs Education Prevention and policy, 2005, 12, 1.
A. Blume, Treating drug problems, John Wiley & Sons, 2005, 336 p.
M. Earleywine, Understanding marijuana. A new look at the scientific evidence, Oxford Univ. Press, April 2005, 344 p.
C.R. Matthews & P. Larah, An examination of Addiction Treatment Completion by Gender and Ethnicity, Journal of Addictions & Offender Counselling, April 2005, vol. 25, 2, p.114.
Carraro I., Le terapie dinamiche di gruppo “brevi” e “a termine” nella cura della dipendenza da sostanze psicoattive, Personalità \ Dipendenze, 2005; 11 (2): 159-177
P. Flores, Addiction as an attachment disorder, Jason Aronson, 2004, 272 p.
K. Wanberg, H. Milkman, D. Timken, Driving with care. Alcohol, other drugs and driving safety education. Alcohol, other drugs and impaired driving offender treatment, Sage Publications, December 2004.
P.M. Monti, S.M. Colby & T. O’Leary, Adolescents alcohol and substance abuse: Reaching teens through brief interventions, Guilford, December 2004, 290 p.
J.E. Smith and R.J. Meyers, Motivating substance abusers to enter treatment. Working with family members, Guilford, December 2004, 290 p.
C.C. Swenson, S.W. Henggerler, I.S. Taylor & O.W. Addison, Multisystemic therapy and neighborhood partnerships: Reducing adolescent violence and substance abuse, Guilford, December 2004, 270 p.
G. Connors, D. Donovan, C. DiClemente, Substance abuse treatment and the stages of change, Guilford, December 2004, 274 p.
P. Taylor, Diagnosis and treatment of substance-related disorders:The Declare model, Allyn & Bacon, 2004
Hibell B., Andersson B., Bjarnason T., Ahlstrom S., Balakireva O., Kokkevi A. Morgan M, The ESPAD Report 2003. Alcohol and other drug use among students in 35 European Countries. The Swedish Council for information on Alcohol and other Drugs (CAN) and the Pompidou Group at the Council of Europe, Stockholm, 2004, pp.436
R.M. Pavarin (a cura di), Uso di sostanze e problemi connessi. Studio sullo street rave parade, Osservatorio Epidemiologico Metropolitano Dipendenze Patologiche, 2004, Bologna, pp.38
A. Rossi, La relazione terapeutica complessa, I gruppi all’interno del carcere, Quaderni di Saman, n. 1 (6/2004), pp 96-125
EMCDDA, Linee guida per la valutazione degli interventi di prevenzione nel campo delle tossicodipendenze, EURISPES ult. ed. 2004.
Kampman K.M. et al. A pilot trial of topiramate for the treatment of cocaine dependence, Drug and Alcohol Dependence, 2004, 75(3), 233-240.
G. Manca, Seduttività del rischio e della trasgressione in adolescenza, Aree: periodico dell’Associazione Regionale Età Evolutiva, n.47 (mar. 2003), pp. 39-43.
2.4. Organizzazione dei Servizi
Goldman J., Kinnear S., Chung J., Rothman D., New York City’s initiatives on diabetes and HIV/AIDS: implications for patient care, public health, and medical professionalism, American Journal of Public Health, 2008; 98: 807-813
Myers J., Frieden T., Bherwani K., Henning K., Ethics in public health research: privacy and public health at risk: public health confidentiality in the digital age, American Journal of Public Health, 2008; 98: 793-801
McBride D., McElrath Y., VanderWaal C., Chriqui J., Myllyluoma J., US public health agency involvement in youth-focused illicit drug policy, planning, and prevention at the local level, 1999–2003, American Journal of Public Health, 2008; 98: 270-277
Saponaro A., Cocaina: uso, abuso e attività dei servizi, Salute e Società. Il Consumo di Sostanze Psicoattive Oggi, 2007; Anno VI (I): 161-174
Foster J., Tyrell K., Cropper V., Hunt N., Two case studies of users involvement in the recruitment for drug services, Drugs-Education Prevention and Policy, 2007; 14 (1): 89-94
O’Shea M., Introducing safer injecting facilities (SIFs) in the Republic of Ireland: “chipping away” at policy change, Drugs-Education Prevention and Policy, 2007; 14 (1): 75-88
Darke S., Havard A., Ross J., Williamson A., Mills K., Teesson M., Changes in the use of medical services and prescription drugs among heroin users over two years, Drug and Alcohol Review, 2007; 26 (2): 153-159
Stoltz J., Wood E., Miller C., Small W., Li K., Tyndall M., et al., Characteristics of young illicit drug injectors who use North America’s first medically supervised safer injecting, Addiction Research and Theory, 2007; 15 (1): 63-69
Strauss S., Astone T., Janetta M., Munoz –Plaza C., Jarlais D., Gwadz M., Hagan H., et al., Correlates of drug treatment program staff’s self efficacy to support their clients’ hepatitis C virus (HCV) related needs, American Journal of Drug and Alcohol Abuse, 2007; 33 (2): 245-251
Watson H., Maclaren W., Kerr S., Staff attitudes towards working with drug users: development of the drug problems perceptions questionnaire, Addiction, 2007; 102 (2): 206-215
Keinan G., Malach-Pines A., Stress and Burnout among prison personnel: sources, outcomes, and intervention strategies, Criminal Justice and Behavior, 2007; 34 (3): 380-398
Larson M., Saitz R., Horton N., Lloyd-Travaglini C., Samet J., Emergency department and hospital utilization among alcohol and drug-dependent detoxification patients without primary medical care, American Journal of Drug and Alcohol Abuse, 2006; 32 (3): 435-452
Restori A., Famiglia, servizio, territorio: una mente in diversi corpi, Personalità / Dipendenze, 2006; 12 (II): 173-181
Nizzoli U., Lanzi A., La committenza ai servizi per gli interventi in caso di consumo di crack/cocaina, Personalità / Dipendenze, 2006; 12 (II): 197-209
Agenzia Comunale per le Tossicodipendenze di Roma. Un monitoraggio dei cittadini sui servizi per le tossicodipendenze, 2006
Lizzola I., Interagire nelle dipendenze. Un percorso di ricerca e formazione, Unicopli, 2005 Nizzoli U., Indicatori sui piani di assistenza concordati tra SERT e centri di salute mentale, CSM, Personalità / Dipendenze, 2006; 12 (I): 19-36
Frati F., Aspetti metodologici e deontologici dell’attività dello psicologo in ambito penale minorile: una rassegna legislativa e bibliografica, Personalità/ Dipendenze, 2006; 12 (III): 229-264
Pocaterra R., Rivera N., Prefettura e tossicodipendenza: quale prevenzione? Il ruolo dei Not nei percorsi a sostegno dell’utenza, Franco Angeli 2005
Longo C., Montatori C., L’integrazione pluralistiche nelle tossicodipendenze. Percorsi formativi e terapeutici, Franco Angeli, 2005
D’Angella F., Mazzoli G., Manoukian F., Cose (mai) viste. Riconoscere il lavoro psicosociale dei Ser.T., Carocci, 2003
Strepparola G., Operare nelle dipendenze patologiche. Mission dei servizi e specializzazione dell’intervento. Comunicazione presentate al I congresso di FeDerSerD, Franco Angeli, 2003
Spinelli E., Se il malato non sparisce… Dalla dipendenza all’interdipendenza nel lavoro dei servizi, Franco Angeli, 1995 Hulse G., Morris N., Arnold-Reed D., et al., Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone., Journal of Substance Abuse Treatment, 2009; 66 (10): 1108 - 1115
|
